PUBLISHER: Polaris Market Research | PRODUCT CODE: 1720524
PUBLISHER: Polaris Market Research | PRODUCT CODE: 1720524
The global endoscopic submucosal dissection market size is expected to reach USD 618.18 million by 2034, according to a new study by Polaris Market Research. The report "Endoscopic Submucosal Dissection Market Size, Share, Trends, Industry Analysis Report: By Product (Gastroscopes and Colonoscopes, Knives, Injection Agents, Tissue Retractors, Graspers/Clips, and Others), Indication, End Use, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.
Endoscopic submucosal dissection (ESD) is a highly specialized endoscopic technique that enables en-bloc resection of gastrointestinal lesions, reducing the need for more invasive surgical interventions. The endoscopic submucosal dissection market is experiencing significant growth due to the rising prevalence of early-stage gastrointestinal (GI) cancers and the increasing demand for minimally invasive procedures. The market growth is also driven by advancements in electrosurgical knives, endoscopic imaging systems, and AI-assisted diagnostics, improving procedural accuracy and clinical outcomes. Market demand is further fueled by the shift toward organ-preserving therapies, particularly in cases of esophageal, gastric, and colorectal cancers.
The endoscopic submucosal dissection market landscape is being shaped by trends such as the integration of robot-assisted endoscopic procedures, enhanced hemostatic techniques, and real-time AI-driven lesion detection systems. Additionally, increasing investments in physician training programs and skill development initiatives are accelerating the adoption of ESD, creating a substantial market opportunity for medical device manufacturers. The market dynamics are also influenced by regulatory approvals for next-generation ESD devices, supporting widespread clinical adoption.
Healthcare institutions are prioritizing cost-effective and efficient treatment modalities, driving preference for advanced endoscopic resection techniques over traditional surgical approaches. Moreover, the rising awareness of early cancer detection and improved access to advanced endoscopic technologies are contributing to the rising demand for ESD. With continuous technological advancements, increasing procedural success rates, and expanding reimbursement frameworks, the adoption of ESD is expected to surge, presenting lucrative endoscopic submucosal dissection market opportunities for stakeholders.
In terms of product, the knives segment accounted for the largest market share in 2024 due to their critical role in precise mucosal dissection, enabling improved en bloc resection of gastrointestinal lesions.
Based on end use, the hospitals segment held the largest market share in 2024 due to the availability of advanced endoscopic infrastructure, specialized medical expertise, and a higher volume of complex ESD procedures.
In 2024, North America accounted for the largest market share due to the increasing adoption of minimally invasive procedures, the rising prevalence of gastrointestinal cancers, and well-established reimbursement policies.
The Asia Pacific endoscopic submucosal dissection market is expected to witness the highest CAGR during the forecast period due to rapid advancements in endoscopic technology, growing awareness of early cancer detection, and increasing healthcare investments.
Some of the global key market players are Boston Scientific Corporation, CONMED Corporation, Cook Group, Creo Medical, FUJIFILM Holdings Corporation, Karl Storz GmbH & Co. KG, Medtronic, Micro-Tech Endoscopy, Olympus Corporation, PENTAX Medical (Hoya Corporation), and STERIS plc.
Polaris Market Research has segmented the endoscopic submucosal dissection market report on the basis of product, indication, end use, and region: